Comment le bénéfice par action récent de 09960.HK se compare-t-il aux attentes ?
Comment les revenus de Kindstar Globalgene Technology, Inc. 09960.HK se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Kindstar Globalgene Technology, Inc. ?
Quel est le score de qualité des bénéfices pour Kindstar Globalgene Technology, Inc. ?
Quand Kindstar Globalgene Technology, Inc. publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Kindstar Globalgene Technology, Inc. ?
Kindstar Globalgene Technology, Inc. a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$1.21
Prix d'ouverture
$1.23
Plage de la journée
$1.2 - $1.23
Plage de 52 semaines
$1.05 - $1.75
Volume
366.0K
Volume moyen
789.1K
BPA (TTM)
-0.12
Rendement en dividend
--
Capitalisation boursière
$1.2B
Qu’est-ce que KINDSTAR GLOBAL ?
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei and currently employs 3,162 full-time employees. The company went IPO on 2021-07-16. The firm includes nine segments. The Hematology Testing segment includes testing services related to blood diseases. The Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. The Infectious Diseases segment includes testing services from the infection department. The Oncology segment includes testing related to oncology diseases. The Neurology segment includes testing services related to neurological diseases. The Maternity-Related Diseases segment includes testing services related to maternity. The Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Scientific Research Services and Cro segment includes research and development services. The Others segment provides other miscellaneous testing services.